Pdt Partners, LLC Cor Medix Inc. Transaction History

Pdt Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $36,586 - $97,564	-12,974 Reduced 31.17%	28,649 $81,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $66,068 - $135,767	24,201 Added 138.91%	41,623 $167,000
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $66,726 - $108,713	17,422 New	17,422 $95,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.